Circ_0058063 contributes to cisplatin-resistance of bladder cancer cells by upregulating B2M through acting as RNA sponges for miR-335-5p

Bladder cancer (BC) is one of the most common malignant tumors of the urinary system, and cisplatin (CDDP) is a critical chemical drug for the treatment of BC. However, CDDP-resistance seriously limits the therapeutic efficacy of this drug for clinical utilization. Thus, identification of pivotal mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ming, Liu, Xuefeng, Zhao, Wenyan, Zhang, Bin, Deng, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943922/
https://www.ncbi.nlm.nih.gov/pubmed/35321689
http://dx.doi.org/10.1186/s12885-022-09419-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943922/
https://www.ncbi.nlm.nih.gov/pubmed/35321689
http://dx.doi.org/10.1186/s12885-022-09419-1

Ejemplares similares